ADMINISTRATIVE CORE (UCLA) Each partnering institution, UCLA and CDU, has established an Administrative Core which will continue to ensure that all participating cores, services and faculty receive the necessary administrative support and coordination for success in the areas of cancer research, research education, and outreach. The Administrative Core will work hand-in-hand with the Planning and Evaluation Core to ensure effective planning, communication and continuous evaluation of partnership activities. The UCLA Administrative Core for the Partnership will be directed by the UCLA PI, Dr. Robin Farias-Eisner, who is a full Professor in the academic series, and Vice Chair, Administrative, and the Chief of Gynecologic Oncology in the Department of Obstetrics and Gynecology, at the David Geffen School of Medicine, at UCLA, and the Principle investigator for the NRG (National Research Group) at UCLA. He will work collaboratively with the CDU PI and CDU Administrative Core Director, Dr. Jay Vadgama. They have balancing strengths and have worked together very well as colleagues for over 9 years, and jointly as PIs of the U54 for the past 2-3 years. Together they have been successful at jointly recruiting U54 faculty; participating in community activities and conferences; and partnering for the evaluation of short-term progress and research activities of the pilot investigators. The Administrative Core at UCLA is and will continue to be comprised of two teams, the Executive Management Team and the Program Leadership Team. The Executive Management Team will be comprised of the core director, the program specialist, and the finance specialist. The Executive Management Team will work closely with, and be guided by, the NCI program director, the Internal Advisory and Program Steering Committees of the Planning and Evaluation Core, and institutional leadership. The Program Leadership Team will consist of all investigators and core leaders and coordinators. The Administrative Core at UCLA will also serve as the hub for documentation, tracking, and integration of facilities, faculty, resources, and projects within the Partnership.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143930-07
Application #
9152247
Study Section
Special Emphasis Panel (ZCA1-PCRB-C)
Program Officer
Ojeifo, John O
Project Start
Project End
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
7
Fiscal Year
2016
Total Cost
$68,281
Indirect Cost
$23,943
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Boonyaratanakornkit, Viroj; Hamilton, Nalo; Márquez-Garbán, Diana C et al. (2018) Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Mol Cell Endocrinol 466:51-72
Elshimali, Yahya I; Wu, Yong; Khaddour, Hussein et al. (2018) Optimization Of Cancer Treatment Through Overcoming Drug Resistance. J Cancer Res Oncobiol 1:
Maxwell, Annette E; Crespi, Catherine M; Arce, Anthony A et al. (2017) Exploring the effects of longstanding academic-community partnerships on study outcomes: A case study. Prev Med Rep 8:101-107
Hamilton, Nalo; Austin, David; Márquez-Garbán, Diana et al. (2017) Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int J Mol Sci 18:
Wu, Y; Vadgama, J V (2017) Androgen Receptor as a Potential Target for Treatment of Breast Cancer. Int J Cancer Res Mol Mech 3:
Wu, Yong; Yu, Xiaoting; Yi, Xianghua et al. (2017) Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis. Cancer Res 77:1383-1394
Bhat, Kruttika; Sarkissyan, Marianna; Wu, Yanyuan et al. (2017) GRO? overexpression drives cell migration and invasion in triple negative breast cancer cells. Oncol Rep 38:21-30
Wu, Yanyuan; Tran, Trinh; Dwabe, Sami et al. (2017) A83-01 inhibits TGF-?-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat 163:449-460
Gelfand, Robert; Vernet, Dolores; Bruhn, Kevin W et al. (2017) Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features. Int J Oncol 50:49-65
Dong, Yunzhou; Wu, Yong; Cui, Mei-Zhen et al. (2017) Lysophosphatidic Acid Triggers Apoptosis in HeLa Cells through the Upregulation of Tumor Necrosis Factor Receptor Superfamily Member 21. Mediators Inflamm 2017:2754756

Showing the most recent 10 out of 52 publications